drugset / Trial / NCT04236414
Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A study to find out whether olaparib is safe and well tolerated when administered to children and adolescents with solid tumours.
Timeline
- Start
- 2020-01-14
- Primary completion
- 2025-02-04
- Completion
- 2025-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olaparib | Small molecule | 15 mg | Oral |
| Subject | Olaparib | Small molecule | 19.5 mg | Oral |
| Subject | Olaparib | Small molecule | 25 mg | Oral |
| Subject | Olaparib | Small molecule | 100 mg | Oral |